Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression

BACKGROUND: In an 8-week, randomized, placebo-controlled, double-blind study, an extended-release formulation of quetiapine, quetiapine XR, demonstrated efficacy and safety in Japanese patients with bipolar depression. Bipolar disorder is a chronic disease requiring continuous treatment. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanba, Shigenobu, Murasaki, Mitsukuni, Koyama, Tsukasa, Takeuchi, Masahiro, Shimizu, Yuriko, Arita, Eri, Kuroishi, Kentaro, Kamei, Shinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595609/
https://www.ncbi.nlm.nih.gov/pubmed/31242884
http://dx.doi.org/10.1186/s12888-019-2181-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595609/
https://www.ncbi.nlm.nih.gov/pubmed/31242884
http://dx.doi.org/10.1186/s12888-019-2181-9

Ejemplares similares